The content of this event is designed to be product- and service-neutral. We confirm that the scientific management and speakers disclose any potential conflicts of interest to participants.
The one-time costs for the technical implementation for all courses are approximately €150,000.
Disclorure conflict of interest forProf. Dr. Heinz Wiendl der letzten 12 Monaten (Stand 24.04.2026)
:
Honoraria for membership on Scientific Advisory Boards: Alexion, Argenx, Biocryst, Bristol Myers Squibb, Cellerys, Galapagos, Janssen, Merck, Novartis, Sandoz-Hexal, uniQure Biopharma B.V.
Honoraria for lectures and travel expenses: Alexion, AOCN, AstraZeneca, Biogen, BGP Products Operations GmbH, Bristol Myers Squibb, CEMCAT, EPG Health/Medthority, Genzyme, Kohlhammer, Merck, MS at the Limits, Neurodiem, NMSS, Novartis, Ology, Roche, Sanofi, Springer, Streamed Up, TEVA, Uvet, WebMD Global.
Honoraria for consulting activities: Alexion, Argenx, Argobio, Bristol Myers Squibb, Dianthus, EMD Serono, Fondazione Cariplo, Idorsia, Immunic, Immunovant, INmune Bio / Syneos Health, Janssen, LTS, Lundbeck, Merck, Muna Therapeutics, Myrobalan Therapeutics, Novartis, PSL Group, Red Nucleus, Roche, Samsung, Sangamo, Sanofi, Swiss Multiple Sclerosis Society, Teladoc Health, Toleranzia, UCB, Viatris.
Research grants and study funding: German Research Foundation (DFG), German Myasthenia Society (Deutsche Myasthenie Gesellschaft e.V.), European Union, Alexion, Amicus Therapeutics Inc., Argenx, Biogen, CSL Behring, F. Hoffmann-La Roche, Genzyme, Merck KGaA, Novartis, Roche, UCB Biopharma.
Die Inhalte dieser Veranstaltung werden produkt- und dienstleistungsneutral gestaltet. Wir bestätigen, dass die wissenschaftliche Leitung und die Referenten potentielle Interessenskonflikte gegenüber den Teilnehmern offenlegen.
Offenlegung von Interessenskonflikten für Prof. Dr. Heinz Wiendl der letzten 12 Monaten (Stand 24.06.2026):
Honorar Mitglied Scientific Advisory Boards: Alexion, Argenx, Biocryst, Bristol Myers Squibb, Cellerys, Galapagos, Janssen, Merck, Novartis, Sandoz-Hexal, uniQure biopharma B.V.
Honorar für Vortragstätigkeiten und Reisekosten: Alexion, AOCN, AstraZeneca, Biogen, BGP Products Operations GmbH, Bristol Myers Squibb, CEMCAT, EPG Health/Medthority, Genzyme, Kohlhammer, Merck, MS at the Limits, Neurodiem, NMSS, Novartis, Ology, Roche, Sanofi, Springer, Streamed up, TEVA, Uvet, WebMD Global.
Honorar für Beratertätigkeiten: Alexion, Argenx, Argobio, Bristol Myers Squibb, Dianthus, EMD Serono, Fondazione Cariplo, Idorsia, Immunic, Immunovant, INmune Bio_Syneos Health, Janssen, LTS, Lundbeck, Merck, Muna, herapeutics, Myrobalan Therapeutics, Novartis, PSL Group, Red Nucleus, Roche, Samsung, Sangamo, Sanofi, Swiss Multiple Sclerosis Society, Teladochealth, Toleranzia, UCB, Viatris
Forschungs- und Studiengelder: Deutsche Forschungsgemeinschaft (DFG), Deutsche Myasthenie Gesellschaft e.V., European Union, Alexion, Amicus Therapeutics Inc., Argenx, Biogen, CSL Behring, F. Hoffmann - La Roche, Genzyme, Merck KgaA, Novartis, Roche, UCB Biopharma.
